The CB<sub>1</sub>Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability - Concepedia

Concepedia

Publication | Open Access

The CB<sub>1</sub>Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability

DOI Full Paper Access

71

Citations

44

References

2016

Year

Aliou B. Gueye, Yaroslaw Pryslawsky, José Trigo, Nafsika Poulia, Foteini Delis, Katerina Antoniou, Michaël Loureiro, Steve R. Laviolette, Kiran Vemuri, Alexandros Makriyannis,

The International Journal of Neuropsychopharmacology

Abstract

Our results indicate that AM4113 could be a promising therapeutic option for the prevention of relapse to nicotine-seeking while lacking anxiety/depression-like side effects.

References

	Year	Citations

Page 1